-Company ramps up clinical diagnostics product development-
NEW HAVEN, Conn., July 17 /PRNewswire/ -- HistoRx, Inc., announced today that William C. Sullivan has joined the company as Senior Vice President, Diagnostic Operations. In this newly created position, Mr. Sullivan will be responsible for expanding the role of the company's diagnostics development process, overseeing the manufacture of HistoRx diagnostic products, and growing revenues associated with the clinical diagnostics services provided by HistoRx.
"I am delighted to have this opportunity to join HistoRx at such a promising time for the company," said Mr. Sullivan. "HistoRx has made impressive progress over the past several years in building a company that is well-poised with its unique AQUA(R) technology platform to capitalize on the tremendous opportunity that personalized medicine represents, powered by an expanding revenue-generating services operation. I look forward to leading the commercial laboratory operations for HistoRx's growing number of pharmaceutical and biotechnology customers as we focus concurrently on developing and commercializing our own line of HistoRx high-value clinical diagnostic products."
"The HistoRx management team, operations workforce, and Board of
Directors are very pleased to have Bill join the company," said Rana Gupta,
CEO of HistoRx. "Over the past year, we have moved the company rapidly
toward our ultimate goal of introducing HistoRx-branded, FDA-approved,
quantitative diagnostic tests that run on the proprietary HistoRx AQUA(R)
technology. We believe these assays will offer significant improvements
over currently available immunohistochemistry-based tests and drive
standards-based market adoption of our technology. With his impressive
diagnostics industry expertise combined with operations management
experience, Bill will be a tremendous asset to HistoRx in leading our
commercial laboratory operations and diagnostic product developm
|SOURCE HistoRx, Inc.|
Copyright©2008 PR Newswire.
All rights reserved